NovaBay Pharmaceuticals Inc (FRA:B9P0)
€ 2.8 0 (0%) Market Cap: 3.14 Mil Enterprise Value: 4.29 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Q3 2021 NovaBay Pharmaceuticals Inc Earnings Call Transcript

Nov 11, 2021 / 09:30PM GMT
Release Date Price: €586.78 (-4.01%)
Operator

Good day and welcome to the NovaBay Pharmaceuticals third-quarter 2021 financial results conference call. All participants will be in listen-only mode. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Jody Cain. Please go ahead.

Jody Cain
LHA Investor Relations - SVP

This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel; Andy Jones, Chief Financial Officer; and Dr. Audrey Kunin, the company's new Chief Product Officer.

I would like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results. In particular, there is uncertainty about the future operations of NovaBay's newly acquired subsidiary, DERMAdoctor, and the duration and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot